Results 141 to 150 of about 5,575 (204)

Assessment of the control measures of the category A diseases of Animal Health Law: Burkholderia mallei (Glanders). [PDF]

EFSA J, 2022
EFSA Panel on Animal Health and Welfare (AHAW), Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Schmidt CG, Herskin M, Michel V, Miranda Chueca MÁ, Padalino B, Pasquali P, Spoolder H, Ståhl K, Velarde A, Viltrop A, Winckler C, Gubbins S, Laroucau K, Antoniou SE, Aznar I, Broglia A, Lima E, Van der Stede Y, Zancanaro G, Roberts HC.   +28 more
europepmc   +1 more source

Monoclonal antibodies against Yersinia pestis lipopolysaccharide detect bacteria cultured at 28 degrees C or 37 degrees C.

, 2002
Four monoclonal antibodies were generated against Yersinia pestis lipopolysaccharide by immunising mice with a cell surface preparation from Y. pestis strain 1255. In an ELISA the monoclonal antibodies reacted with live whole cells of Y. pestis strain GB
Prior, JL, Titball, RW
core   +1 more source

Development of a sensitive competitive enzyme-linked immunosorbent assay for serodiagnosis of Burkholderia mallei, a Tier 1 select agent. [PDF]

PLoS Negl Trop Dis, 2021
Wernery U, Chan E, Raghavan R, Teng JLL, Syriac G, Siu SY, Joseph M, Yeung ML, Jia L, Cai JP, Chiu TH, Lau SKP, Woo PCY.   +12 more
europepmc   +1 more source

Burkholderia mallei [PDF]

, 2020
openaire   +1 more source

Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.

Experimental biology and medicine (Maywood, N.J.), 2007
Much effort has been devoted to the development of mouse monoclonal antibodies that react specifically with Burkholderia mallei and Burkholderia pseudomallei for diagnostic and/or therapeutic purposes. Our present study focused on the screening of a phage-displayed nonimmune human single-chain Fv (scFv) antibody library against heat-killed B.
Nianxiang, Zou, Tamara, Newsome, Bingjie, Li, Shien, Tsai, Shyh-Ching, Lo   +4 more
openaire   +1 more source

Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders Pathogenesis. [PDF]

Front Microbiol, 2021
Chiang CY, Zhong Y, Ward MD, Lane DJ, Kenny T, Rosario-Acevedo R, Eaton BP, Treviño SR, Chance TB, Hu M, Worsham PL, Waag DM, Moore RT, Cazares LH, Cote CK, Zhou Y, Panchal RG.   +16 more
europepmc   +1 more source

Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei. [PDF]

NPJ Vaccines, 2020
Tapia D, Sanchez-Villamil JI, Torres AG.
europepmc   +1 more source

Detection of <i>Burkholderia mallei</i> in Microbiological Culture: A Comparative Analysis of PCR Primer Sets. [PDF]

Pathogens
Moriya JCK, Suniga PAP, Araújo ACL, Santos MG, Rieger JSG, Mantovani C, Jardim R, Silva MR, Araújo FR, Santos LR.   +9 more
europepmc   +1 more source

The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Burkholderia mallei and provides protection against lethal aerosol challenge. [PDF]

Virulence, 2020
Dyke JS, Huertas-Diaz MC, Michel F, Holladay NE, Hogan RJ, He B, Lafontaine ER.   +6 more
europepmc   +1 more source

Comparison of immunogenicity of 17 Burkholderia mallei antigens and whole cell lysate using indirect ELISA. [PDF]

J Vet Med Sci
Ichikawa Y, Iinuma Y, Okagawa T, Shimbo R, Enkhtuul B, Khurtsbaatar O, Kinoshita Y, Niwa H, Aoshima K, Kobayashi A, Batbaatar V, Ohashi K, Kimura T.   +12 more
europepmc   +1 more source